2024 Fall Conference | C6 - Anti-amyloid Therapy Update

Date Friday 10/25/24

Time 01:00 PM - 02:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jonathan Graff-Radford, MD, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Upon completion of this program, participants should be able to appraise major findings from recent clinical trials of anti-amyloid monoclonal antibody therapies in Alzheimer's disease; summarize mechanisms, risk factors, and safety monitoring for amyloid-related imaging abnormalities; and understand common scenarios in evaluating eligibility for anti-amyloid therapy.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic

Program Materials

Event Timeline
01:00 PM - 01:30 PM PDT	Speaker	Overview of Trials and Updates Parichita Choudhury, MD
01:30 PM - 02:00 PM PDT	Speaker	ARIA Petrice M. Cogswell, MD, PhD
02:00 PM - 02:30 PM PDT	Speaker	Lessons Learned from One Year of Availability and Cases Jonathan Graff-Radford, MD, FAAN, Petrice M. Cogswell, MD, PhD

Faculty Disclosures
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.
Petrice M. Cogswell, MD, PhD	Dr. Cogswell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Cogswell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kaplan.
Parichita Choudhury, MD	The institution of Dr. Choudhury has received research support from Lewy Body Dementia Association. The institution of Dr. Choudhury has received research support from Arizona Alzheimer's Consortium.